Showing results (2411-2420 of 10,003) with videos related to

Sort By:
Pageof 1,001
Leukemia & Lymphoma|September 6, 2023
Response and local control in patients treated with low-dose radiotherapy for tumoral mycosis fungoidesJoseph Pena, Deborah Cull, Lindsay C Strowd, et al.
Leukemia & Lymphoma|September 1, 2023
Consecutive day dosing of high-dose cytarabine consolidation over 3 days is resource-efficient and safe in older adult patients with acute myeloid leukemiaRithin Nedumannil, Emily Batterham, Emily Harding, et al.
Leukemia & Lymphoma|September 10, 2023
Utility of routine pulmonary function test after autologous hematopoietic cell transplantation in lymphomaParastoo B Dahi, Sheila Kenny, Jessica Flynn, et al.
Leukemia & Lymphoma|September 15, 2023
Ethnic disparities in presentation but not outcome in multiple myeloma patients: a multicenter retrospective study in Northern IsraelNajib Dally, Myriam Baranes, Luiza Akria, et al.
Leukemia & Lymphoma|September 14, 2023
Influence of treatment intensity and medical comorbidities in older adults with peripheral T cell lymphomaMax J Gordon, Zhigang Duan, Hui Zhao, et al.
Leukemia & Lymphoma|April 1, 2026
Validation of prognostic indices in adult T-cell leukemia/lymphoma and their prognostic value at the start of second-line treatmentDaisuke Nakamura, Takuya Ueno, Sei-Ichiro Nakabeppu, et al.
Leukemia & Lymphoma|March 20, 2026
Predictors and timing of venous thromboembolism and overall survival in lymphomaAsaad Trabolsi, Thomas E Plate, Tessa Lavorgna, et al.
Leukemia & Lymphoma|April 22, 2026
Clinicopathological factors associated with the prognosis and relapse of primary cutaneous marginal zone lymphoma: a retrospective cohort studyIk Jun Moon, Jihun Choi, Joon Min Jung, et al.
Leukemia & Lymphoma|June 10, 2026
Luspatercept and thrombotic events in patients with myelodysplastic syndrome: a target trial emulation framework using TriNetX databaseNikhil Vojjala, Mahmoud Nassar, Sushmitha Nanjareddy, et al.
Leukemia & Lymphoma|June 10, 2026
Treatment utilization and outcomes in patients with mycosis fungoides and Sézary syndrome receiving mogamulizumab in community and academic practice in the United States clinical practiceB M Haverkos, C Chang, R Ristuccia, et al.
Pageof 1,001